Publication | Closed Access

The direct factor Xa inhibitor Rivaroxaban reduces platelet activation in congestive heart failure

ThrombopoiesisThrombosisHeart FailureCardiovascular DiseaseBlood PlateletMedicineCardiovascular PharmacologyPharmacotherapyCongestive Heart FailurePlatelet AntagonistPharmacologyAnticoagulantCardiologyPlatelet Activation